Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others.[ Read More ]
The intrinsic value of one EHC stock under the base case scenario is HIDDEN Compared to the current market price of 98.8 USD, Encompass Health Corporation is HIDDEN
Current Assets | 842 M |
Cash & Short-Term Investments | 69.1 M |
Receivables | 612 M |
Other Current Assets | 161 M |
Non-Current Assets | 5.26 B |
Long-Term Investments | 110 M |
PP&E | 3.51 B |
Other Non-Current Assets | 1.64 B |
Current Liabilities | 656 M |
Accounts Payable | 170 M |
Short-Term Debt | 48.9 M |
Other Current Liabilities | 438 M |
Non-Current Liabilities | 3.15 B |
Long-Term Debt | 2.91 B |
Other Non-Current Liabilities | 237 M |
Revenue | 4.8 B |
Cost Of Revenue | 3.87 B |
Gross Profit | 934 M |
Operating Expenses | 694 M |
Operating Income | 732 M |
Other Expenses | 370 M |
Net Income | 362 M |
Net Income | 362 M |
Depreciation & Amortization | 274 M |
Capital Expenditures | -583 M |
Stock-Based Compensation | 50.6 M |
Change in Working Capital | 50.3 M |
Others | 171 M |
Free Cash Flow | 268 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
3 months ago
Aug 13, 2024
|
Sell 1.05 M USD
|
COLTHARP DOUGLAS E
EVP & Chief Financial Officer |
- 12162
|
86.33 USD |
3 months ago
Aug 13, 2024
|
Sell 8.53 K USD
|
COLTHARP DOUGLAS E
EVP & Chief Financial Officer |
- 98
|
87.03 USD |
5 months ago
May 24, 2024
|
Sell 850 K USD
|
Charbonneau Elissa Joy
Chief Medical Officer |
- 10000
|
85.02 USD |
6 months ago
May 06, 2024
|
Sell 1.22 M USD
|
Darby John Patrick
EVP, Gen Counsel & Secretary |
- 14543
|
83.94 USD |
6 months ago
May 03, 2024
|
Bought 167 K USD
|
CARMICHAEL GREG D
Director |
+ 2000
|
83.73 USD |
6 months ago
Apr 30, 2024
|
Sell 3.75 M USD
|
Tarr Mark J
President & CEO |
- 44976
|
83.27 USD |
1 year ago
Nov 13, 2023
|
Sell 711 K USD
|
COLTHARP DOUGLAS E
EVP & Chief Financial Officer |
- 11215
|
63.39 USD |
1 year ago
Aug 17, 2023
|
Sell 577 K USD
|
Charbonneau Elissa Joy
Chief Medical Officer |
- 8294
|
69.58 USD |
1 year ago
Aug 16, 2023
|
Sell 1.8 M USD
|
Tarr Mark J
President & CEO |
- 25330
|
71.06 USD |
1 year ago
Feb 10, 2023
|
Sell 1.09 M USD
|
COLTHARP DOUGLAS E
EVP & Chief Financial Officer |
- 17895
|
60.78 USD |
2 years ago
Oct 31, 2022
|
Bought 100 K USD
|
CARMICHAEL GREG D
Director |
+ 1830
|
54.67 USD |
2 years ago
Aug 17, 2022
|
Sell 1.09 M USD
|
Tarr Mark J
President & CEO |
- 20449
|
53.25 USD |
2 years ago
May 05, 2022
|
Bought 66.5 K USD
|
O'Connor Kevin J.
director: |
+ 1000
|
66.48 USD |
2 years ago
Dec 02, 2021
|
Bought 20 K USD
|
Williams Terrance
Director |
+ 354
|
56.61 USD |
3 years ago
Mar 08, 2021
|
Sell 699 K USD
|
Price Andrew L
Chief Accounting Officer |
- 8589
|
81.4 USD |
4 years ago
Nov 17, 2020
|
Sell 500 K USD
|
Charbonneau Elissa Joy
Chief Medical Officer |
- 6650
|
75.22 USD |
4 years ago
May 28, 2020
|
Sell 1.74 M USD
|
COLTHARP DOUGLAS E
EVP & Chief Financial Officer |
- 23011
|
75.73 USD |
4 years ago
May 28, 2020
|
Sell 37.3 K USD
|
COLTHARP DOUGLAS E
EVP & Chief Financial Officer |
- 490
|
76.15 USD |
4 years ago
May 15, 2020
|
Sell 162 K USD
|
Jacobsmeyer Barbara Ann
President, Inpatient Hospitals |
- 2500
|
64.73 USD |
4 years ago
May 14, 2020
|
Sell 1.62 M USD
|
Tarr Mark J
President & CEO |
- 26132
|
61.92 USD |
4 years ago
Mar 12, 2020
|
Sell 118 K USD
|
CORRELL DONALD L
Director |
- 2000
|
59.04 USD |
4 years ago
Mar 12, 2020
|
Bought 491 K USD
|
Anthony April Kaye Bullock
CEO & President, Home Health |
+ 8083
|
60.76 USD |
4 years ago
Mar 12, 2020
|
Bought 1.23 M USD
|
Anthony April Kaye Bullock
CEO & President, Home Health |
+ 20580
|
59.95 USD |
4 years ago
Mar 12, 2020
|
Bought 2.45 M USD
|
Anthony April Kaye Bullock
CEO & President, Home Health |
+ 41607
|
58.91 USD |
4 years ago
Mar 12, 2020
|
Bought 2.26 M USD
|
Anthony April Kaye Bullock
CEO & President, Home Health |
+ 38882
|
58.09 USD |
4 years ago
Mar 12, 2020
|
Bought 615 K USD
|
Anthony April Kaye Bullock
CEO & President, Home Health |
+ 10738
|
57.29 USD |
4 years ago
Mar 12, 2020
|
Bought 249 K USD
|
Anthony April Kaye Bullock
CEO & President, Home Health |
+ 4410
|
56.44 USD |
4 years ago
Mar 12, 2020
|
Bought 38.2 K USD
|
Anthony April Kaye Bullock
CEO & President, Home Health |
+ 700
|
54.5 USD |
4 years ago
Mar 11, 2020
|
Bought 64.1 K USD
|
HIGDON LEO I JR
Director |
+ 1000
|
64.07 USD |
4 years ago
Mar 11, 2020
|
Bought 2.57 M USD
|
Anthony April Kaye Bullock
CEO & President, Home Health |
+ 40000
|
64.24 USD |